Skip to content

Abstract 11361: Right Ventricular-Pulmonary Arterial Coupling as a Predictor of Mortality After Transcatheter Aortic Valve Replacement

Nov 2026 · Circulation · 0 citations

Abstract

Background: Right ventricular-pulmonary arterial (RV-PA) coupling, measured by the TAPSE/RVSP ratio, reflects right-sided contractile reserve under afterload stress. Its prognostic value in patients undergoing transcatheter aortic valve replacement (TAVR) is not well established. Hypothesis: Pre-procedural RV-PA uncoupling (TAPSE/RVSP ≤0.51 mm/mmHg) independently predicts long-term all-cause mortality and outperforms TAPSE alone in patients undergoing TAVR. Methods: We studied 1,597 TAVR patients (March 2011-December 2025) at Mayo Clinic, categorized as coupled (TAPSE/RVSP >0.51 mm/mmHg; n=749) or uncoupled (≤0.51 mm/mmHg; n=848). Baseline characteristics, echocardiographic parameters, and survival were compared. Unadjusted and adjusted Cox proportional hazards models evaluated the risk of death from TAPSE/RVSP and TAPSE, both modeled as continuous predictors using restricted cubic splines and adjusted for age, sex, Charlson Comorbidity Index, LVEF, and AVA. Median follow-up was 3.8 years (IQR: 1.6-6.4), during which 643 deaths occurred. Results: TAVR utilization increased steadily from 2011 to 2021. Uncoupled patients had lower TAPSE (16 vs. 22 mm; p<0.001) and higher RVSP (51 vs. 32 mmHg; p<0.001). Survival was significantly worse in uncoupled versus coupled patients (p<0.001); 1-, 3-, and 5-year estimates were 85.9%, 64.0%, and 42.1% versus 94.1%, 83.7%, and 63.5%, respectively. ( Figure 1 ) Similarly, patients with abnormal TAPSE (≤1.7 cm) had lower survival (84.6%, 64.6%, 41.1%) than those with normal TAPSE (>1.7 cm; 92.9%, 78.0%, 58.4%; p<0.001). ( Figure 2 ) TAPSE/RVSP added significant predictive value over TAPSE alone (partial χ 2 =58.3; p<0.001) with superior discrimination (C-index: 0.678 vs. 0.655; adequacy: 0.98 vs. 0.79). In adjusted models, TAPSE/RVSP remained independently associated with mortality (HR per IQR decrease: 1.94 [95% CI: 1.54-2.45]; p<0.001), and uncoupled patients carried a 75% higher adjusted mortality risk (HR: 1.75 [95% CI: 1.47-2.10]; p<0.001). Conclusions: RV-PA uncoupling is common in TAVR candidates and is a strong, independent predictor of long-term mortality. TAPSE/RVSP outperforms TAPSE alone and should be incorporated into routine pre-TAVR risk assessment.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.